Genomic surveillance can help recognize how SARS-CoV-2 spreads in care homes Kumar Jeetendra | March 4, 2021 Care homes are at high risk of experiencing outbreaks of COVID-19, the disease brought on by SARS-CoV-2. Older people and people affected by heart disease, respiratory disease and type 2 diabetes – all of which increase with age – are at greatest risk of severe disease and even death, which makes the care home population …
Diphtheria is developing to get antibiotic-resistant safe and could prompt vaccine escape Kumar Jeetendra | March 8, 2021 Diphtheria – a comparatively easily-preventable infection – is evolving to become immune to a range of types of antibiotics and in the future could lead to vaccine escape, warn an international group of researchers in the UK and India. The researchers, led by scientists at the University of Cambridge, say that the impact of COVID-19 …
INTEGRA’s electronic pipettes empower reproducible examination in microbial analysis Kumar Jeetendra | March 17, 2021 Bacterial evolution studies involve analysis of large sample numbers, requiring compact, reproducible pipetting processes to effectively characterize the qualities of different strains. Dr Astrid Altamirano-Junqueira, who completed her doctoral studies into the growth of bacterial motility in the School of Biological Studies at Reading University, discussed how these digital pipettes aided her research:”My focus was …
Researchers describe the systems that manage embryonic stem cells Kumar Jeetendra | March 26, 2021 Scientists at the Proteomics Core Unit of the Spanish National Cancer Research Centre (CNIO), headed by Javier Muñoz, have clarified the mechanisms, unknown to date, included in maintaining embryonic stem cells in the best possible condition for their use in regenerative medicine. The results, published in Nature Communications, helps to find novel stem-cell therapies for …
Scientists use genetics to recognize likely drugs for early administration of COVID-19 Kumar Jeetendra | April 12, 2021 A new study using human genetics indicates researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages. The findings appeared online in the journal Nature Medicine at March 2021. The purpose is to identify present drugs, either FDA-approved or in clinical development for other conditions, that can …
Genetic variants that sway protein restricting in immune cells can cause autoimmune disease Kumar Jeetendra | April 17, 2021 Certain genetic variants that cause modified protein binding in immune cells, are also seen in people at high risk of some autoimmune diseases, new research has found. Researchers from the Wellcome Sanger Institute, Josep Carreras Leukaemia Research Institute in Spain, and the MRC London Institute of Medical Sciences (LMS) discovered that specific genetic variants, which …
NIAID sets up a clinical research organization to improve comprehension of child asthma Kumar Jeetendra | April 25, 2021 This nationwide network will conduct observational studies and clinical trials to improve understanding of asthma and develop prevention and treatment approaches tailored to children of low-income families residing in urban communities. NIAID plans to provide approximately $70 million over seven years to support the CAUSE network. This new initiative expands and extends NIAID’s long-standing attempts …
Novel platform has potential to detect many disease-related biomarkers in just one test Kumar Jeetendra | April 28, 2021 Most conventional molecular diagnostics usually detect only one disease-related biomarker. Fantastic examples are the PCR tests now used to diagnose COVID-19 by detecting a particular sequence from SARS-CoV-2. Such so-called singleplex methods give reliable results because they are”calibrated” to a single biomarker. However, determining whether a patient is infected with a new SARS-CoV-2 version or …
Researchers develop experimental direct-acting antiviral treatment to treat COVID-19 Kumar Jeetendra | May 18, 2021 An international team of scientists from the Menzies Health Institute Queensland (MHIQ) at Griffith University and from City of Hope, a research and treatment center for cancer, diabetes and other life-threatening diseases in the U.S., have developed an experimental direct-acting antiviral therapy to treat COVID-19. Conventional antivirals reduce symptoms and help people recover earlier. Examples …
New testing protocols for SARS-CoV-2 can handle a huge number of tests inside 48 hours Kumar Jeetendra | May 25, 2021 Researchers in the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less than 48 hours. The method, called SARSeq, is printed in the journal Nature Communications and might be adapted to many more pathogens. The COVID-19 pandemic has lasted more than a year and continues to …
Growing genomic research into different ancestries yields more and better outcomes Kumar Jeetendra | June 1, 2021 Currently published in Nature Genetics, their findings demonstrate that expanding research into different ancestries yields more and better results, in addition to ultimately benefitting global patient care. Up to now nearly 87 percent of genomic research of the type was conducted in Europeans. The global study team examined data across a wide assortment of cohorts, …
Study recognizes master regulator behind the improvement of antibody delivering cells Kumar Jeetendra | September 24, 2021 The main regulator that controls the production of antibody-producing cells was identified in a research conducted by scientists from Weill Cornell Medicine. These findings offer new insights into the functioning in the immunity system. It also can help to understand how tissues form and how cancers are triggered. The study, which was published on September. …
